Page last updated: 2024-08-25

methotrexate and Abnormality, Heart

methotrexate has been researched along with Abnormality, Heart in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeCampli, W; Piggott, KD; Riddle, E; Sorbello, A1
Gui, YH; Jiang, Q; Song, HY; Sun, SN; Wang, YX; Zhong, T1
Abbattista, AD; Catena, G; Di Donato, R; La Vigna, G; Parisi, F; Squitieri, C; Vinciguerra, G1
Blakemore, KJ; Duhl, AJ; Escallon, CS; Nguyen, C1

Other Studies

4 other study(ies) available for methotrexate and Abnormality, Heart

ArticleYear
Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure?
    Pediatric cardiology, 2011, Volume: 32, Issue:4

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Angiography; Cardiac Surgical Procedures; Craniofacial Abnormalities; Diagnosis, Differential; Echocardiography; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Infant; Intellectual Disability; Lupus Erythematosus, Systemic; Male; Methotrexate; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects

2011
[Folic acid antagonist methotrexate causes the development malformation of heart and down-regulates the BMP2b and HAS2 expressions in zebrafish].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2007, Volume: 9, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Down-Regulation; Folic Acid Antagonists; Gene Expression Regulation; Glucuronosyltransferase; Heart Defects, Congenital; Hyaluronan Synthases; Methotrexate; Polymerase Chain Reaction; Zebrafish; Zebrafish Proteins

2007
Twelve years of cyclosporine in pediatric heart transplantation: what is the future?
    Transplantation proceedings, 1998, Volume: 30, Issue:5

    Topics: Adolescent; Azathioprine; Cardiomyopathies; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Methotrexate; Reoperation; Retrospective Studies; Steroids; Survival Rate; Time Factors

1998
Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester.
    Obstetrics and gynecology, 2002, Volume: 99, Issue:4

    Topics: Abnormalities, Multiple; Adolescent; Bone and Bones; Craniofacial Abnormalities; Depression; Digestive System; Digestive System Abnormalities; Female; Fetal Death; Heart Defects, Congenital; Humans; Infant, Newborn; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Psoriasis; Sertraline; Ultrasonography, Prenatal

2002